Literature DB >> 19624083

Pathogenesis and management of irritable bowel syndrome.

Praveen Mathew1, Shobna J Bhatia.   

Abstract

The exact cause of irritable bowel syndrome (IBS) is not known. Multiple factors, like genetic, gut motility, visceral hypersensitivity, psychosocial factors and immune-mediated factors, are thought to contribute to the symptom complex of IBS. Till date an 'IBS gene' has not been defined, and there is a need for further studies. The concept that IBS as a diagnosis of exclusion is not acceptable any more. The treatment of IBS is targeted at the management of constipation, diarrhoea and abdominal pain and includes pharmacotherapy with tegaserod, alosetron and lubiprostone. Cognitive behavioral therapy is very beneficial.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624083

Source DB:  PubMed          Journal:  Trop Gastroenterol        ISSN: 0250-636X


  8 in total

Review 1.  Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications.

Authors:  M Larauche; C Kiank; Y Tache
Journal:  J Physiol Pharmacol       Date:  2009-12       Impact factor: 3.011

Review 2.  A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome.

Authors:  Mahnaz Darvish-Damavandi; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

3.  Effectiveness of acupuncture to treat irritable bowel syndrome: a meta-analysis.

Authors:  Guan-Qun Chao; Shuo Zhang
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 4.  Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

5.  A new acupuncture method for management of irritable bowel syndrome: A randomized double blind clinical trial.

Authors:  Rahmatollah Rafiei; Mehdi Ataie; Mohammad Arash Ramezani; Ali Etemadi; Behrooz Ataei; Hamidreza Nikyar; Saman Abdoli
Journal:  J Res Med Sci       Date:  2014-10       Impact factor: 1.852

6.  Electroacupuncture at He-Mu points reduces P2X4 receptor expression in visceral hypersensitivity.

Authors:  Xinxin Guo; Jifei Chen; Yuan Lu; Luyi Wu; Zhijun Weng; Ling Yang; Yuhu Xin; Xianming Lin; Yi Liang; Jianqiao Fang
Journal:  Neural Regen Res       Date:  2013-08-05       Impact factor: 5.135

7.  Electroacupuncture diminishes P2X2 and P2X3 purinergic receptor expression in dorsal root ganglia of rats with visceral hypersensitivity.

Authors:  Zhijun Weng; Luyi Wu; Yuan Lu; Lidong Wang; Linying Tan; Ming Dong; Yuhu Xin
Journal:  Neural Regen Res       Date:  2013-03-25       Impact factor: 5.135

Review 8.  Serum biomarkers for irritable bowel syndrome.

Authors:  Alexandra Chira; Dan Lucian Dumitrascu
Journal:  Clujul Med       Date:  2015-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.